Post‐marketing surveillance of quetiapine fumarate extended‐release tablets in patients with bipolar depression by Taro Kishi, Nakao Iwata, Hiroyuki Irie, Masaru Aikawa

Connect to this object online.

A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression by Taro Kishi, Hiroshi Nakamura, Tadafumi Kato, Nakao Iwata

Connect to this object online.

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis by Taro Kishi, Toshikazu Ikuta, Yuki Matsuda, Nakao Iwata

Connect to this object online.

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review by Taro Kishi, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, Nakao Iwata

Connect to this object online.

Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan by Taro Kishi, Tadashi Nosaka, Kenji Sakuma, Makoto Okuya, Nakao Iwata

Connect to this object online.

Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan by Taro Kishi, Reiji Yoshimura, Kenji Sakuma, Makoto Okuya, Nakao Iwata

Connect to this object online.

Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis by Taro Kishi, Kenji Sakuma, Takeo Saito, Atsuo Nakagawa, Masaki Kato, Nakao Iwata

Connect to this object online.

Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study by Taro Kishi, Makoto Okuya, Kenji Sakuma, Yohei Otaka, Eiichi Saitoh, Nakao Iwata

Connect to this object online.

Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta‐analysis by Taro Kishi, Kenji Sakuma, Masakazu Hatano, Takenori Okumura, Masaki Kato, Hajime Baba, Nakao Iwata

Connect to this object online.

Recent findings on subjective well‐being and physical, psychiatric, and social comorbidities in individuals with schizophrenia: A literature review by Yupeng He, Ayako Tanaka, Taro Kishi, Yuanying Li, Masaaki Matsunaga, Shinichi Tanihara, Nakao Iwata, Atsuhiko Ota

Connect to this object online.

Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis by Taro Kishi, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Hikaru Hori, Masaki Kato, Nakao Iwata

Connect to this object online.

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study by Taro Kishi, Kenji Sakuma, Makoto Okuya, Kohei Ninomiya, Kazuto Oya, Momoko Kubo, Yuki Matsui, Ikuo Nomura, Yuji Okuyama, Shinji Matsunaga, Nakao Iwata

Connect to this object online.

Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review by Taro Kishi, Maika Nishida, Michinori Koebis, Takehiro Taninaga, Kenzo Muramoto, Naoki Kubota, Margaret Moline, Kenji Sakuma, Makoto Okuya, Ikuo Nomura, Nakao Iwata

Connect to this object online.

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-... by Naomichi Okamoto, Keita Watanabe, Hirofumi Tesen, Atsuko Ikenouchi, Ryohei Igata, Yuki Konishi, Tomoya Natsuyama, Rintaro Fujii, Shingo Kakeda, Taro Kishi, Nakao Iwata, Reiji Yoshimura

Connect to this object online.

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta‐analysis of double‐bl... by Kazuto Oya, Kenji Sakuma, Satoru Esumi, Yasuhiko Hashimoto, Masakazu Hatano, Yuki Matsuda, Yuki Matsui, Nobumi Miyake, Ikuo Nomura, Makoto Okuya, Nakao Iwata, Masaki Kato, Ryota Hashimoto, Kazuo Mishima, Norio Watanabe, Taro Kishi

Connect to this object online.